Factors associated with the prevalence of arteriovenous fistulas in hemodialysis patients in the HEMO study. Hemodialysis (HEMO) Study Group.

BACKGROUND Arteriovenous (AV) fistulas are the vascular access of choice for hemodialysis patients, but only about 20% of hemodialysis patients in the United States dialyze with fistulas. There is little information known about the factors associated with this low prevalence of fistulas. METHODS Multiple logistic regression analysis was used to evaluate the independent contribution of factors associated with AV fistula use among patients enrolled in the HEMO Study. The analysis was conducted in 1824 patients with fistulas or grafts at 45 dialysis units (15 clinical centers). RESULTS Thirty-four percent of the patients had fistulas. The prevalence of fistulas varied markedly from 4 to 77% among the individual dialysis units (P < 0.001). Multiple regression analysis revealed five demographic and clinical factors that were each independently associated with a lower likelihood of having a fistula, even after adjustment for dialysis unit. Specifically, the prevalence of fistulas was lower in females than males [adjusted odds ratio (AOR) 0.37, 95% CI, 0.28 to 0.48], lower in patients with peripheral vascular disease than in those without (AOR 0.55, 95% CI, 0.38 to 0.79), lower in blacks than in non-blacks (AOR 0.64, 95% CI, 0.46 to 0.89), lower in obese patients (AOR per 5 kg/m(2) body mass index, 0.76, 95% CI, 0.65 to 0.87), and lower in older patients (AOR per 10 years, 0.85, 95% CI, 0.78 to 0.94). The differences in the prevalence of fistulas among the dialysis units remained statistically significant (P < 0.001) after adjustment for these demographic and clinical factors. Finally, there were substantial variations in the prevalence of fistulas even among dialysis units in a single metropolitan area. CONCLUSIONS Future efforts to increase the prevalence of fistulas in hemodialysis patients should be directed at both hemodialysis units and patient subpopulations with a low fistula prevalence.

[1]  D. Redden,et al.  Predictors of adequacy of arteriovenous fistulas in hemodialysis patients. , 1999, Kidney international.

[2]  R. Hobson,et al.  A strategy for increasing use of autogenous hemodialysis access procedures: impact of preoperative noninvasive evaluation. , 1998, Journal of vascular surgery.

[3]  M. Robbin,et al.  A multidisciplinary approach to hemodialysis access: prospective evaluation. , 1998, Kidney international.

[4]  R. Hobson,et al.  Vein transposition in the forearm for autogenous hemodialysis access. , 1997, Journal of vascular surgery.

[5]  E. Friedman,et al.  Determinants of type of initial hemodialysis vascular access. , 1997, American journal of nephrology.

[6]  M. Pauly,et al.  Predictors of type of vascular access in hemodialysis patients. , 1996, JAMA.

[7]  M. Rocco,et al.  Utilization of inpatient and outpatient resources for the management of hemodialysis access complications. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  H. Feldman,et al.  Hemodialysis vascular access morbidity. , 1996, Journal of the American Society of Nephrology : JASN.

[9]  J. Sands,et al.  Optimizing hemodialysis access: a teaching tool. , 1996, Nephrology news & issues.

[10]  G. Beck,et al.  The Hemodialysis (HEMO) Study: Rationale for Selection of Interventions , 1996 .

[11]  W. I. Carney,et al.  Comparison of basilic vein and polytetrafluoroethylene for brachial arteriovenous fistula. , 1994, Journal of vascular surgery.

[12]  P. Gerlag,et al.  The brachiocephalic elbow fistula: a useful alternative angioaccess for permanent hemodialysis. , 1994, Journal of vascular surgery.

[13]  J. L. Porile,et al.  Preservation of vascular access. , 1993, Journal of the American Society of Nephrology : JASN.

[14]  D. Windus.  Permanent vascular access: a nephrologist's view. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  S. Schwab,et al.  Vascular access: concepts for the 1990s. , 1992, Journal of the American Society of Nephrology : JASN.

[16]  J. Klinowski,et al.  Aluminosilicate-lnduced Free Radical Generation by Murine Brain Glial Cells in vitro: Potential Significance in the Aetiopathogenesis of Alzheimer's Dementia , 1992 .

[17]  D. Churchill,et al.  Canadian Hemodialysis Morbidity Study. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  L. R. King,et al.  Comparison of autogenous fistula versus expanded polytetrafluoroethylene graft fistula for angioaccess in hemodialysis. , 1986, American journal of surgery.

[19]  R M Hakim,et al.  Vascular Access for Hemodialysis Patency Rates and Results of Revision , 1985, Annals of surgery.

[20]  O. Winsett,et al.  Complications of Vascular Access for Hemodialysis , 1985, Southern medical journal.